How An Advertising Platform Can Maximize Clinical Trial Site Stipends
JERICHO, N.Y., April 19, 2018 /PRNewswire-iReach/ -- Clinical trial sites often need to recruit patients for studies beyond their patient databases. Sponsors recognize this and typically budget for site stipends when they contract with them. While earmarking funds for clinical trial patient recruitment makes sense, how that money gets spent is equally as important. This can create a problem for both sites and sponsors.
Sites are in the business of providing healthcare; that's their core competency. They typically lack the time, expertise and resources to properly implement a patient recruitment outreach campaign. As a result, site stipends are often misspent, which leads to poor results. What's worse is neither sites nor sponsors know why their efforts aren't productive, because there's no system in place to monitor their outreach campaigns. Sometimes these funds are not spent at all, which defeats the sponsors purpose.
One approach to solving this problem is not surprisingly rooted in a technology solution. For example, CTM, a clinical trialrecruitment firm, has developed a user-friendly site advertising management platform called "SAM™" to assist sites and protect sponsors. SAM™ streamlines the entire patient recruitment advertising process, helping to drive successful, properly targeted campaigns. It's a one-stop portal that enable sites to place patient recruitment advertising and outreach at their convenience, with the support of advertising professionals.
Several benefits of the SAM™ platform include:
Professionally produced advertising. A branded campaign with a consistent theme and cohesive advertising materials can help build credibility and increase patient recruitment. SAM™ ensures that study branding remains constant since CTM produces digital, TV, radio and print assets that are customized for each site and available directly through the portal. This replaces the site having to produce advertising on their own.
Media planning. Sites can leverage CTM's 23 years of proven clinical trial patient recruitment media planning and buying expertise to help meet their patient recruitment goals. All sites have to do is determine their timing and budget, and CTM will post media options to the portal individually tailored to each site's market. If they need help or want to offer input, CTM has live SiteSupport Specialists to address their needs.
Increased ROI. Cohesive, professionally produced advertising, targeted media planning and CTM's expert media buying help increase patient flow and deliver better ROI for sites and sponsors.
Eliminates Ad Trafficking. Sites that use the SAM™ platform are not responsible for delivering ad materials to the media. CTM handles it for them.
Reduces Accounting Burden. Sites are busy processing their own payables and receivables. They don't have time to reconcile and pay various media invoices. With SAM™, they don't have to; CTM does it for them. This ensures that advertising purchases are monitored and full value is received. In addition, the portal tracks each site's advertising spend so they can easily view remaining funds.
Sponsors continue to allocate stipends to sites for patient recruitment. An advertising portal such as SAM™ provides a turnkey solution to maximizing ROI for both sites and sponsors.
About CTM
CTM is a global clinical trial recruitment and retention agency. They have been a top vendor to sponsors, CROs, sites, and other patient recruitment providers since 1995. Clients rely on CTM to determine the most cost-effective ways to recruit and retain patients for clinical studies. They seek out CTM's team of dedicated personnel and unique and effective technology solutions that help accelerate the patient recruitment and retention process. For more information log onto http://www.ctmenrolls.com.
Media Contact: Allisa DiPolito, fishbat, 6317908549, [email protected]
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
SOURCE CTM
iReach LastName, iReachCompany, 111-222-3333, [email protected]
Share this article